Precio de cierre
Otros sitios de cotización
|
||
- | - |
Resumen de negocios
Ventas por actividad
KRW en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Distribution
64,7
%
| 54 058 | 54,3 % | 63 412 | 64,7 % | +17,30 % |
Medicare
29,4
%
| 34 707 | 34,8 % | 28 802 | 29,4 % | -17,01 % |
Others
4,5
%
| 4 810 | 4,8 % | 4 413 | 4,5 % | -8,26 % |
Construction and Engineering
1,4
%
| 5 886 | 5,9 % | 1 362 | 1,4 % | -76,86 % |
Bio Development
0,0
%
| 130 | 0,1 % | 1 | 0,0 % | -99,12 % |
Ventas por región
KRW en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
South Korea
99,6
%
| 99 484 | 99,9 % | 97 630 | 99,6 % | -1,86 % |
Overseas
0,4
%
| 107 | 0,1 % | 361 | 0,4 % | +236,66 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 11/12/15 |
Ki-Hwan Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Geun-Shik Lee
BRD | Director/Board Member | 51 | - |
Young-Hyun Kim
AUD | Comptroller/Controller/Auditor | 66 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 11/12/15 |
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yoon-Gi Baek
BRD | Director/Board Member | 61 | - |
In-Geun Jang
BRD | Director/Board Member | 48 | - |
Geun-Shik Lee
BRD | Director/Board Member | 51 | - |
Soo-Ja Choi
BRD | Director/Board Member | 59 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 106 166 293 | 87 903 312 ( 82,80 %) | 71 752 ( 0,0676 %) | 82,80 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
HLB CO., LTD. 2.05% | 2 681 798 | 2.05% | 215 770 173 $ |
HLB PHARMACEUTICAL CO., LTD. 13.61% | 4 322 044 | 13.61% | 106 636 063 $ |
HLB SCIENCE INC. 20.47% | 3 365 165 | 20.47% | 8 278 373 $ |
HLB INNOVATION CO.,LTD. 2.87% | 2 074 688 | 2.87% | 6 920 122 $ |
223 638 | 0.28% | 1 817 130 $ |
Información de la empresa
HLB Life Science Co., Ltd.
3-502, Pangyo Seven Venture Valley 1 15 Pangyo-ro 228beon-gil
13487, Seongnam-si
+
http://www.hlb-ls.comSector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+20,94 % | 72,78 mil M | |
-1,26 % | 24,24 mil M | |
+8,80 % | 8586,52 M | |
+8,25 % | 8378,07 M | |
-19,42 % | 8092,48 M | |
+5,56 % | 4805,93 M | |
+16,83 % | 4315,76 M | |
-1,83 % | 4050,85 M | |
+26,97 % | 3794,7 M |
- Bolsa de valores
- Acciones
- Acción A067630
- Acción
- Empresa EnergySolutions Co Ltd